Bacterial Skin Infections
📧 Sign up to get email alerts when something new happens for Bacterial Skin Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections [Phase 2]
Phase 2 trial comparing CEM-102 to linezolid for acute bacterial skin infections has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Retapamulin Microdialysis Feasibility Study [Phase 1]
Phase 1 microdialysis feasibility study of retapamulin for bacterial skin infections has been completed.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: The Effect of Pomegranate on Aging and Inflammation of the Skin [NA]
A completed clinical trial evaluating the effect of pomegranate on skin aging, inflammation, and skin pathogen defense (bacteria).
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia
A multicenter Russian study assessed antimicrobial resistance of Gram-positive and Gram-negative clinical strains to ceftaroline and other a…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: United States Pharmacovigilence Retapamulin-Prescribing
This Clinical Trial Update reports on pharmacovigilance and prescribing of retapamulin in the United States, sponsored by GlaxoSmithKline. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-06-17FDA Approved: CLINDAMYCIN PHOSPHATE — Original Application (i3 Pharmaceuticals, LLC)
FDA approved the original application for CLINDAMYCIN PHOSPHATE TOPICAL (clindamycin phosphate topical) by i3 Pharmaceuticals, LLC as a gene…
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections [Phase 2]
Phase 2 safety and efficacy study of a fluoroquinolone for complicated skin infections completed; results posted.